NHI logo

National Health Investors, Inc. Stock Price

NYSE:NHI Community·US$3.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

NHI Share Price Performance

US$0
-71.40 (-100.00%)
US$85.75
Fair Value
US$0
-71.40 (-100.00%)
Price US$0

NHI Community Narratives

·
Fair Value US$85.75 16.1% undervalued intrinsic discount

US Senior Housing Demand Will Unlock Future Potential

1users have liked this narrative
0users have commented on this narrative
15users have followed this narrative

Trending Discussion

Updated Narratives

NHI logo

NHI: Improving Senior Housing Occupancy Will Support Higher Future P/E Multiples

Fair Value: US$85.75 16.1% undervalued intrinsic discount
15 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Established dividend payer and good value.

2 Risks
3 Rewards

National Health Investors, Inc. Key Details

US$404.7m

Revenue

US$89.1m

Cost of Revenue

US$315.6m

Gross Profit

US$167.7m

Other Expenses

US$147.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
3.05
77.98%
36.54%
82.8%
View Full Analysis

About NHI

Founded
1991
Employees
32
CEO
D. Mendelsohn
WebsiteView website
www.nhireit.com

National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility investments. NHI's portfolio consists of independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, senior living campuses, skilled nursing facilities and specialty hospitals. National Health Investors, Inc. was established on October 15th 1991 and was incorporated in 1991 in Maryland and is based in Murfreesboro, Tennessee.

Recent NHI News & Updates

Seeking Alpha Jun 04

National Health Investors: An Investment-Grade Healthcare REIT With Portfolio Growth And More

Summary National Health Investors is rated a buy, driven by robust macro demand for senior care, portfolio expansion, and a compelling 5% dividend yield. NHI demonstrates strong top-line growth, geographic diversity, and resilient 5-year revenue trends, with recent acquisitions further solidifying its market presence. Despite modest FFO growth expectations and technical bearishness, NHI benefits from an investment-grade Fitch rating, prudent leverage, and strong ROE among peers. I see fair valuation with +9% upside potential by Dec. 2027, balanced by operator concentration and interest rate risks. Read the full article on Seeking Alpha
Narrative Update Jun 02

NHI: Improving Senior Housing Occupancy Will Support Higher Future P/E Multiples

Analysts have trimmed the National Health Investors fair value estimate from $89.00 to $85.75, reflecting updated price targets and model revisions that incorporate slightly higher discount rates, modestly lower revenue growth and profit margin assumptions, and a reduced future P/E outlook. Analyst Commentary Recent research updates on National Health Investors highlight a mix of optimism and caution, with several firms adjusting price targets while maintaining a generally constructive stance on the stock.

Recent updates

No updates